Cross Shawn - Insider Non-Derivative Transactions at Cyclo Therapeutics, Inc. (CYTH) - (SEC)
Updated on January 3, 2026.
According to recent SEC insider information filed on Feb 27, 2025, Cross Shawn's relationship to Cyclo Therapeutics, Inc. (CYTH) is Director, and currently has 136,346 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CYTH insiders.
Related Topics: SEC Topic List.
Data Source: SEC.
Cross Shawn - Insider Non-Derivative Transactions of CYTH Common Stock
Cross Shawn - Insider Non-Derivative Transactions at CYTH
Items per page:
25
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Feb 28, 2025 | Acquisition -- (Common Stock) | 28597 | 0 | 136346 |
| Nov 16, 2024 | Acquisition -- (Common Stock) | 17228 | 0 | 107749 |
| Aug 17, 2024 | Acquisition -- (Common Stock) | 9028 | 0 | 90521 |
| Jun 4, 2024 | Acquisition -- (Common Stock) | 8887 | 0 | 81493 |
| Dec 28, 2023 | Acquisition -- (Common Stock) | 72606 | 0 | 72606 |
Popular Topics:
Find us
Copyright © Beautify Data LLC. All Rights Reserved.